APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nasal Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nasal Vaccines Industry Growth and Trends Forecast to 2032

Report ID 174015860119 December 2025101 pages

Choose your research edition.

Industry ResearchNasal Vaccines Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Nasal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Nasal Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nasal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nasal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nasal Vaccines include Abbott, Sanofi, GlaxoSmithKline, AstraZeneca, Serum Institute of India, PharmaJet and Crossject, INJEX Pharma GmbH, BioDiem and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nasal Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nasal Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nasal Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nasal Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nasal Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nasal Vaccines Market by Company

Abbott

Sanofi

GlaxoSmithKline

AstraZeneca

Serum Institute of India

PharmaJet and Crossject

INJEX Pharma GmbH

BioDiem

Bharat Biotech

Antares Pharma

Nasal Vaccines Segment by Type

Flu Vaccines

COVID-19 Vaccines

Other Vaccines

Nasal Vaccines Segment by Application

Adult

Children

Nasal Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nasal Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nasal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Flu Vaccines Table 2. Major Company of COVID-19 Vaccines Table 3. Major Company of Other Vaccines Table 4. Global Nasal Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nasal Vaccines Sales by Type (2021-2026) & (K Doses) Table 6. Global Nasal Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Nasal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Nasal Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global Nasal Vaccines Price by Type (2021-2026) & (US$/Dose) Table 10. Global Nasal Vaccines Sales by Type (2027-2032) & (K Doses) Table 11. Global Nasal Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Nasal Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Nasal Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global Nasal Vaccines Price by Type (2027-2032) & (US$/Dose) Table 15. North America Nasal Vaccines Sales by Type (2021-2026) & (K Doses) Table 16. North America Nasal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Nasal Vaccines Sales by Type (2021-2026) & (K Doses) Table 18. Europe Nasal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Nasal Vaccines Sales by Type (2021-2026) & (K Doses) Table 20. Asia-Pacific Nasal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Nasal Vaccines Sales by Type (2021-2026) & (K Doses) Table 22. Latin America Nasal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Nasal Vaccines Sales by Type (2021-2026) & (K Doses) Table 24. Middle East and Africa Nasal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Nasal Vaccines Industry Trends Table 26. Nasal Vaccines Industry Drivers Table 27. Nasal Vaccines Industry Opportunities and Challenges Table 28. Nasal Vaccines Industry Restraints Table 29. Global Nasal Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Nasal Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global Nasal Vaccines Sales by Company (2021-2026) & (K Doses) Table 32. Global Nasal Vaccines Sales Share by Company (2021-2026) Table 33. Global Nasal Vaccines Market Price by Company (2021-2026) & (US$/Dose) Table 34. Global Nasal Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nasal Vaccines Major Company Production Sites and Headquarters Table 36. Global Nasal Vaccines Company, Product Type & Application Table 37. Global Nasal Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Nasal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nasal Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Nasal Vaccines Sales by Region (2021-2026) & (K Doses) Table 42. Global Nasal Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Nasal Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Nasal Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global Nasal Vaccines Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 46. Global Nasal Vaccines Sales by Region (2027-2032) & (K Doses) Table 47. Global Nasal Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Nasal Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Nasal Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global Nasal Vaccines Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2027-2032) Table 51. Global Nasal Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Nasal Vaccines Sales by Application (2021-2026) & (K Doses) Table 53. Global Nasal Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Nasal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Nasal Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global Nasal Vaccines Price by Application (2021-2026) & (US$/Dose) Table 57. Global Nasal Vaccines Sales by Application (2027-2032) & (K Doses) Table 58. Global Nasal Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Nasal Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Nasal Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global Nasal Vaccines Price by Application (2027-2032) & (US$/Dose) Table 62. North America Nasal Vaccines Sales by Application (2021-2026) & (K Doses) Table 63. North America Nasal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Nasal Vaccines Sales by Application (2021-2026) & (K Doses) Table 65. Europe Nasal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Nasal Vaccines Sales by Application (2021-2026) & (K Doses) Table 67. Asia-Pacific Nasal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Nasal Vaccines Sales by Application (2021-2026) & (K Doses) Table 69. Latin America Nasal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Nasal Vaccines Sales by Application (2021-2026) & (K Doses) Table 71. Middle East and Africa Nasal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Company Information Table 73. Abbott Business Overview Table 74. Abbott Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 75. Abbott Nasal Vaccines Product Portfolio Table 76. Abbott Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 80. Sanofi Nasal Vaccines Product Portfolio Table 81. Sanofi Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Nasal Vaccines Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. AstraZeneca Company Information Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 90. AstraZeneca Nasal Vaccines Product Portfolio Table 91. AstraZeneca Recent Development Table 92. Serum Institute of India Company Information Table 93. Serum Institute of India Business Overview Table 94. Serum Institute of India Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 95. Serum Institute of India Nasal Vaccines Product Portfolio Table 96. Serum Institute of India Recent Development Table 97. PharmaJet and Crossject Company Information Table 98. PharmaJet and Crossject Business Overview Table 99. PharmaJet and Crossject Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 100. PharmaJet and Crossject Nasal Vaccines Product Portfolio Table 101. PharmaJet and Crossject Recent Development Table 102. INJEX Pharma GmbH Company Information Table 103. INJEX Pharma GmbH Business Overview Table 104. INJEX Pharma GmbH Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 105. INJEX Pharma GmbH Nasal Vaccines Product Portfolio Table 106. INJEX Pharma GmbH Recent Development Table 107. BioDiem Company Information Table 108. BioDiem Business Overview Table 109. BioDiem Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 110. BioDiem Nasal Vaccines Product Portfolio Table 111. BioDiem Recent Development Table 112. Bharat Biotech Company Information Table 113. Bharat Biotech Business Overview Table 114. Bharat Biotech Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 115. Bharat Biotech Nasal Vaccines Product Portfolio Table 116. Bharat Biotech Recent Development Table 117. Antares Pharma Company Information Table 118. Antares Pharma Business Overview Table 119. Antares Pharma Nasal Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 120. Antares Pharma Nasal Vaccines Product Portfolio Table 121. Antares Pharma Recent Development Table 122. North America Nasal Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 123. North America Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 124. North America Nasal Vaccines Sales Market Share by Country (2021-2026) Table 125. North America Nasal Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 126. North America Nasal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 127. North America Nasal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Nasal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Nasal Vaccines Market Share by Country (2021-2026) Table 130. North America Nasal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Nasal Vaccines Market Share Forecast by Country (2027-2032) Table 132. Europe Nasal Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 133. Europe Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 134. Europe Nasal Vaccines Sales Market Share by Country (2021-2026) Table 135. Europe Nasal Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 136. Europe Nasal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Nasal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Nasal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Nasal Vaccines Market Share by Country (2021-2026) Table 140. Europe Nasal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Nasal Vaccines Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Nasal Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 144. Asia-Pacific Nasal Vaccines Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Nasal Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 146. Asia-Pacific Nasal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Nasal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Nasal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Nasal Vaccines Market Share by Country (2021-2026) Table 150. Asia-Pacific Nasal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Nasal Vaccines Market Share Forecast by Country (2027-2032) Table 152. Latin America Nasal Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 153. Latin America Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 154. Latin America Nasal Vaccines Sales Market Share by Country (2021-2026) Table 155. Latin America Nasal Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 156. Latin America Nasal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Nasal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Nasal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Nasal Vaccines Market Share by Country (2021-2026) Table 160. Latin America Nasal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Nasal Vaccines Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Nasal Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 164. Middle East and Africa Nasal Vaccines Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Nasal Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 166. Middle East and Africa Nasal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Nasal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Nasal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Nasal Vaccines Market Share by Country (2021-2026) Table 170. Middle East and Africa Nasal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Nasal Vaccines Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Nasal Vaccines Distributors List Table 175. Nasal Vaccines Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Nasal Vaccines Image Figure 2. Global Nasal Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Nasal Vaccines Sales (2021-2032) & (K Doses) Figure 5. Flu Vaccines Image Figure 6. Global Flu Vaccines Sales YoY Growth (2021-2032) & (K Doses) Figure 7. COVID-19 Vaccines Image Figure 8. Global COVID-19 Vaccines Sales YoY Growth (2021-2032) & (K Doses) Figure 9. Other Vaccines Image Figure 10. Global Other Vaccines Sales YoY Growth (2021-2032) & (K Doses) Figure 11. Global Nasal Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Nasal Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America Nasal Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America Nasal Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe Nasal Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Nasal Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Nasal Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Nasal Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Nasal Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Nasal Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Nasal Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Nasal Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Nasal Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (K Doses) Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (K Doses) Figure 29. Global Nasal Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Nasal Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Nasal Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Nasal Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Nasal Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Nasal Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Nasal Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Nasal Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Nasal Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Nasal Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Nasal Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Nasal Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Nasal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 42. North America Nasal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Nasal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Nasal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nasal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 46. Europe Nasal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nasal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nasal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nasal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 50. Asia-Pacific Nasal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nasal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Nasal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nasal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 54. Latin America Nasal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nasal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Nasal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nasal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 58. Middle East and Africa Nasal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nasal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Nasal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Nasal Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Nasal Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Flu Vaccines
  • COVID-19 Vaccines
  • Other Vaccines
Applications
  • Adult
  • Children
Companies covered
  • Abbott
  • Sanofi
  • GlaxoSmithKline
  • AstraZeneca
  • Serum Institute of India
  • PharmaJet and Crossject
  • INJEX Pharma GmbH
  • BioDiem
  • Bharat Biotech
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nasal Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nasal Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nasal Vaccines Market by Type
  6. 1.3.1 Flu Vaccines
  7. 1.3.2 COVID-19 Vaccines
  8. 1.3.3 Other Vaccines
  9. 1.4 Global Nasal Vaccines Market Size by Type
  10. 1.4.1 Global Nasal Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Nasal Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Nasal Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Nasal Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Nasal Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Nasal Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Nasal Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Nasal Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nasal Vaccines Industry Trends
  2. 2.2 Nasal Vaccines Industry Drivers
  3. 2.3 Nasal Vaccines Industry Opportunities and Challenges
  4. 2.4 Nasal Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nasal Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Nasal Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Nasal Vaccines Price (2021-2026)
  4. 3.4 Global Nasal Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nasal Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Nasal Vaccines Company, Product Type & Application
  7. 3.7 Global Nasal Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nasal Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nasal Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nasal Vaccines Tier 1, Tier 2, and Tier 3
4 Nasal Vaccines Regional Status and Outlook
  1. 4.1 Global Nasal Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nasal Vaccines Historic Market Size by Region
  3. 4.2.1 Global Nasal Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nasal Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nasal Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nasal Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Nasal Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nasal Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nasal Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nasal Vaccines by Application
  1. 5.1 Nasal Vaccines Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Nasal Vaccines Market Size by Application
  5. 5.2.1 Global Nasal Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Nasal Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Nasal Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Nasal Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Nasal Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Nasal Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Nasal Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Nasal Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Nasal Vaccines Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Nasal Vaccines Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Nasal Vaccines Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Nasal Vaccines Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Serum Institute of India
  26. 6.5.1 Serum Institute of India Company Information
  27. 6.5.2 Serum Institute of India Business Overview
  28. 6.5.3 Serum Institute of India Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Serum Institute of India Nasal Vaccines Product Portfolio
  30. 6.5.5 Serum Institute of India Recent Developments
  31. 6.6 PharmaJet and Crossject
  32. 6.6.1 PharmaJet and Crossject Company Information
  33. 6.6.2 PharmaJet and Crossject Business Overview
  34. 6.6.3 PharmaJet and Crossject Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PharmaJet and Crossject Nasal Vaccines Product Portfolio
  36. 6.6.5 PharmaJet and Crossject Recent Developments
  37. 6.7 INJEX Pharma GmbH
  38. 6.7.1 INJEX Pharma GmbH Company Information
  39. 6.7.2 INJEX Pharma GmbH Business Overview
  40. 6.7.3 INJEX Pharma GmbH Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 INJEX Pharma GmbH Nasal Vaccines Product Portfolio
  42. 6.7.5 INJEX Pharma GmbH Recent Developments
  43. 6.8 BioDiem
  44. 6.8.1 BioDiem Company Information
  45. 6.8.2 BioDiem Business Overview
  46. 6.8.3 BioDiem Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BioDiem Nasal Vaccines Product Portfolio
  48. 6.8.5 BioDiem Recent Developments
  49. 6.9 Bharat Biotech
  50. 6.9.1 Bharat Biotech Company Information
  51. 6.9.2 Bharat Biotech Business Overview
  52. 6.9.3 Bharat Biotech Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bharat Biotech Nasal Vaccines Product Portfolio
  54. 6.9.5 Bharat Biotech Recent Developments
  55. 6.10 Antares Pharma
  56. 6.10.1 Antares Pharma Company Information
  57. 6.10.2 Antares Pharma Business Overview
  58. 6.10.3 Antares Pharma Nasal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Antares Pharma Nasal Vaccines Product Portfolio
  60. 6.10.5 Antares Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Nasal Vaccines Sales by Country
  2. 7.1.1 North America Nasal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nasal Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Nasal Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nasal Vaccines Market Size by Country
  6. 7.2.1 North America Nasal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nasal Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Nasal Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nasal Vaccines Sales by Country
  2. 8.1.1 Europe Nasal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nasal Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Nasal Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nasal Vaccines Market Size by Country
  6. 8.2.1 Europe Nasal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nasal Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nasal Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nasal Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Nasal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nasal Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nasal Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nasal Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Nasal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nasal Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nasal Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nasal Vaccines Sales by Country
  2. 10.1.1 South America Nasal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nasal Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Nasal Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nasal Vaccines Market Size by Country
  6. 10.2.1 South America Nasal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nasal Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Nasal Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nasal Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Nasal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nasal Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nasal Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nasal Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Nasal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nasal Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nasal Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nasal Vaccines Value Chain Analysis
  2. 12.1.1 Nasal Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nasal Vaccines Production Mode & Process
  7. 12.2 Nasal Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nasal Vaccines Distributors
  10. 12.2.3 Nasal Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst